Evidence map›Paper›PMID 41441665›Full record

ArticleVaccines2025

Safety and Cross-Neutralizing Immunity Against SARS-CoV-2 Omicron Sub-Variant After a Booster Dose with SOBERANA

Dagmar García-Rivera, Meiby Rodríguez-González, Beatriz Paredes-Moreno, Rinaldo Puga-Gomez, Yariset Ricardo-Delgado, Carmen Valenzuela Silva, Sonsire Fernández-Castillo, Rocmira Pérez-Nicado, Laura Rodríguez-Noda, Darielys Santana-Mederos and 8 more

Abstract read
In one paragraph

Article in Vaccines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Dagmar García-RiveraFinlay Vaccine Institute, 200 and 21 Street, Havana 11600, Cuba.ORCID 0000-0002-2099-1791
Meiby Rodríguez-GonzálezFinlay Vaccine Institute, 200 and 21 Street, Havana 11600, Cuba.
Beatriz Paredes-MorenoFinlay Vaccine Institute, 200 and 21 Street, Havana 11600, Cuba.
Rinaldo Puga-GomezPediatric Hospital "Juan Manuel Márquez", Havana 11500, Cuba.
Yariset Ricardo-DelgadoPediatric Hospital "Juan Manuel Márquez", Havana 11500, Cuba.
Carmen Valenzuela SilvaFinlay Vaccine Institute, 200 and 21 Street, Havana 11600, Cuba.
Sonsire Fernández-CastilloFinlay Vaccine Institute, 200 and 21 Street, Havana 11600, Cuba.ORCID 0000-0001-5329-5971
Rocmira Pérez-NicadoFinlay Vaccine Institute, 200 and 21 Street, Havana 11600, Cuba.ORCID 0000-0002-1657-6130
Laura Rodríguez-NodaFinlay Vaccine Institute, 200 and 21 Street, Havana 11600, Cuba.
Darielys Santana-MederosFinlay Vaccine Institute, 200 and 21 Street, Havana 11600, Cuba.
Yanet Climent-RuizFinlay Vaccine Institute, 200 and 21 Street, Havana 11600, Cuba.
Enrique Noa-RomeroNational Civil Defense Research Laboratory, San José de las Lajas 32700, Cuba.
Otto Cruz-SuiNational Civil Defense Research Laboratory, San José de las Lajas 32700, Cuba.
Belinda Sánchez-RamírezCenter for Molecular Immunology, 15th Ave. and 216 Street, Havana 11600, Cuba.
Tays Hernández-GarcíaCenter for Molecular Immunology, 15th Ave. and 216 Street, Havana 11600, Cuba.
Ariel Palenzuela-DiazCenter of Immunoassays, 134 and 25 Street, Havana 11600, Cuba.
Yury Valdés-BalbínFinlay Vaccine Institute, 200 and 21 Street, Havana 11600, Cuba.
Vicente G Vérez-BencomoFinlay Vaccine Institute, 200 and 21 Street, Havana 11600, Cuba.

Funding

National Funds for Sciences and Technology from the Ministry of Science, Technology and Environment, Cuba 2020-20
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

booster doseCOVID-19 vaccinecross-neutralizing immunityOmicron variantSOBERANA

Identifiers

PMID41441665
PMCPMC12737616

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.